[Insulin formulations].
Lill
N
N
Aventis Pharma Deutschland GmbH, Pharmaceutical Sciences, H770 65926 Frankfurt am Main. Norbert.Lill@aventis.com
D002626:Chemistry, Pharmaceutical; D005079:Excipients; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage* / Q000737:chemistry / Q000627:therapeutic use
D005079:Excipients; D007004:Hypoglycemic Agents; D007328:Insulin